Search research articles
Contact Us
Filters
Showing results (521-530 of 544) with videos related to
Page
of 55
Sort By:
BMC Public Health
|
February 27, 2024
Social factors associated with self-reported changes in mental health symptoms among youth in the COVID-19 pandemic: a cross-sectional survey
Stephana Julia Moss, Maia Stelfox, Eric McArthur, et al.
Human Vaccines & Immunotherapeutics
|
February 23, 2024
The evolution of vaccine hesitancy through the COVID-19 pandemic: A semi-structured interview study on booster and bivalent doses
Jeanna Parsons Leigh, Emily A FitzGerald, Stephana Julia Moss, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 29, 2026
A controlled human infection model for symptomatic pertussis in North America using the pertactin-producing clinical isolate D420
May S ElSherif, Kara L Redden, Joanne M Langley, et al.
Human Vaccines & Immunotherapeutics
|
January 13, 2026
Parental acceptability of new RSV preventive therapies for infants: A cross-sectional survey in Canada
Tiffany Fitzpatrick, Jeanna Parsons Leigh, Rebecca Brundin-Mather, et al.
CMAJ Open
|
December 23, 2017
Case-control study of household contacts to examine immunological protection from <i>Bordetella pertussis</i> transmission - study protocol
Shelly Bolotin, Caitlin Johnson, Susan Quach, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
June 21, 2017
Assessing the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a randomized clinical trial
May S ElSherif, Catherine Brown, Donna MacKinnon-Cameron, et al.
Vaccine
|
September 16, 2025
Safety and immunogenicity of COVAC-2, a Sepivac SWE™ adjuvanted SARS-CoV-2 recombinant protein vaccine in healthy adults; a randomized controlled first-in-human dose-escalation trial
Glenn Hamonic, Elodie Pastural, Supriya Arora, et al.
The Journal of Pediatrics
|
August 10, 2022
Revaccination and Adverse Event Recurrence in Patients with Adverse Events following Immunization
Caroline E Muñoz, Beth MacDonald, Anne Pham-Huy, et al.
The Journal of Infectious Diseases
|
July 13, 2013
Immunogenicity and safety of an inactivated quadrivalent influenza vaccine candidate: a phase III randomized controlled trial in children
Joanne M Langley, Alfonso Carmona Martinez, Archana Chatterjee, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC
|
November 10, 2018
Vaccination Against Influenza in Pregnancy: A Survey of Canadian Maternity Care Providers
Eve Dubé, Dominique Gagnon, Kyla Kaminsky, et al.
Page
of 55
Search research articles
Search
Showing results (521-530 of 544) with videos related to
Sort By:
Page
of 55
BMC Public Health
|
February 27, 2024
Social factors associated with self-reported changes in mental health symptoms among youth in the COVID-19 pandemic: a cross-sectional survey
Stephana Julia Moss, Maia Stelfox, Eric McArthur, et al.
Human Vaccines & Immunotherapeutics
|
February 23, 2024
The evolution of vaccine hesitancy through the COVID-19 pandemic: A semi-structured interview study on booster and bivalent doses
Jeanna Parsons Leigh, Emily A FitzGerald, Stephana Julia Moss, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 29, 2026
A controlled human infection model for symptomatic pertussis in North America using the pertactin-producing clinical isolate D420
May S ElSherif, Kara L Redden, Joanne M Langley, et al.
Human Vaccines & Immunotherapeutics
|
January 13, 2026
Parental acceptability of new RSV preventive therapies for infants: A cross-sectional survey in Canada
Tiffany Fitzpatrick, Jeanna Parsons Leigh, Rebecca Brundin-Mather, et al.
CMAJ Open
|
December 23, 2017
Case-control study of household contacts to examine immunological protection from <i>Bordetella pertussis</i> transmission - study protocol
Shelly Bolotin, Caitlin Johnson, Susan Quach, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
June 21, 2017
Assessing the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a randomized clinical trial
May S ElSherif, Catherine Brown, Donna MacKinnon-Cameron, et al.
Vaccine
|
September 16, 2025
Safety and immunogenicity of COVAC-2, a Sepivac SWE™ adjuvanted SARS-CoV-2 recombinant protein vaccine in healthy adults; a randomized controlled first-in-human dose-escalation trial
Glenn Hamonic, Elodie Pastural, Supriya Arora, et al.
The Journal of Pediatrics
|
August 10, 2022
Revaccination and Adverse Event Recurrence in Patients with Adverse Events following Immunization
Caroline E Muñoz, Beth MacDonald, Anne Pham-Huy, et al.
The Journal of Infectious Diseases
|
July 13, 2013
Immunogenicity and safety of an inactivated quadrivalent influenza vaccine candidate: a phase III randomized controlled trial in children
Joanne M Langley, Alfonso Carmona Martinez, Archana Chatterjee, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC
|
November 10, 2018
Vaccination Against Influenza in Pregnancy: A Survey of Canadian Maternity Care Providers
Eve Dubé, Dominique Gagnon, Kyla Kaminsky, et al.
Page
of 55